Neurocrine Biosciences | سهم





سهم تغيير تاريخ
AbbVie USD 4.94B 22M 2025-09
Acadia Pharmaceuticals USD 29.1M 2.97M 2025-09
Agios Pharmaceuticals USD 32.92M 886K 2025-12
ALKERMES USD 191M 927K 2025-09
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.38B 42M 2025-09
Cytokinetics USD 0 0 2023-12
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Repligen USD 160.32M 4.46M 2025-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


Neurocrine Biosciences سهم - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.